B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.

Huyang XieYu ZhuJunyu ZhangZheng LiuHangcheng FuYifan CaoGaoxiang LiYijun ShenBo DaiJiejie XuDingwei Ye

Published in: BMC cancer (2018)

Our evaluation indicated that B4GALT1 may be a possible prognosticator of MIBC, and it may be a predictive marker for the choice of ACT in pT3/4 or N+ patients.

Keyphrases

end stage renal disease
ejection fraction
poor prognosis
chronic kidney disease
newly diagnosed
spinal cord injury
prognostic factors
skeletal muscle
patient reported outcomes
binding protein